Rheumatology Doctors in Springfield, MO Accepting Medicare

6 Rheumatology doctors found. Showing 1 - 6

Howard R Schwartz, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 3555 S National Ave, Springfield, MO 65807 Phone: 417-875-3462

David Gregory True, D.O. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 909 E Republic Rd, Springfield, MO 65807 Phone: 417-501-2644    Fax: 417-222-3365

Dr. Stanley P. Hayes, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 3231 S National Ave, Springfield, MO 65807 Phone: 417-888-5664    Fax: 417-888-6799

Joseph L Mayus, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3555 S National Ave, Springfield, MO 65807 Phone: 417-875-3000    Fax: 417-875-3490

Bradley Bohman, MD Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 3555 S National Ave Ste 102, Springfield, MO 65807 Phone: 000-000-0000

Stephen D Armstrong, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 3555 S National, Springfield, MO 65807 Phone: 417-875-3000

News Archive

Genentech's BREVACTA study of ACTEMRA on rheumatoid arthritis meets primary endpoint

Genentech, a member of the Roche Group, today announced that the BREVACTA study of ACTEMRA (tocilizumab) given as a subcutaneous (SC) injection to patients with rheumatoid arthritis (RA) met its primary endpoint.

Funding helps researchers to kiss Multiple Sclerosis (MS) goodbye

Murdoch University researchers have received funding to investigate the link between the Epstein-Barr virus infection, more commonly known as glandular fever or the ‘kissing disease', and the debilitating disease Multiple Sclerosis (MS).

Secondhand smoke exposure associated with psychological distress

Exposure to secondhand smoke appears to be associated with psychological distress and the risk of future psychiatric hospitalization among healthy adults, according to a report posted online today that will appear in the August print issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

Merrimack initiates dosing in MM-111 combination Phase 1 study in advanced HER2 positive patients

Merrimack Pharmaceuticals, Inc. announced today that five patients have received therapy in a Phase I clinical study combining MM-111 with multiple standard treatment regimens for patients with advanced HER2 positive (HER2+) solid tumors.

Read more Medical News

› Verified 7 days ago